Profile
Dr. Sebastien Hazard was previously employed as a Chief Medical Officer & Executive Vice President by Imunon, Inc., a Senior VP & Head-Clinical Development by Bicycle Therapeutics Plc, a Head-Clinical Development by GlaxoSmithKline Plc, and a Senior Medical Director-Clinical Development by Tesaro, Inc. He received his MBA from INSEAD.
Former positions of Sebastien Hazard
| Companies | Position | End |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 01/09/2023 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/04/2021 |
| TESARO INC | Chief Tech/Sci/R&D Officer | 01/05/2019 |
| IMUNON, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Sebastien Hazard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Imunon, Inc.
Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
- Stock Market
- Insiders
- Sebastien Hazard
















